J Maral

581 total citations
29 papers, 344 citations indexed

About

J Maral is a scholar working on Oncology, Epidemiology and Immunology. According to data from OpenAlex, J Maral has authored 29 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 5 papers in Epidemiology and 5 papers in Immunology. Recurrent topics in J Maral's work include Cancer Treatment and Pharmacology (6 papers), Chemotherapy-induced cardiotoxicity and mitigation (4 papers) and Cutaneous Melanoma Detection and Management (4 papers). J Maral is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Chemotherapy-induced cardiotoxicity and mitigation (4 papers) and Cutaneous Melanoma Detection and Management (4 papers). J Maral collaborates with scholars based in France and United States. J Maral's co-authors include J. Vinke, B. Escudier, C Jacquillat, I. Florentin, Bertrand Gachot, T Philip, Denis J. David, Sylvie Négrier, Jacques Thèze and B. Dupont and has published in prestigious journals such as Cancer, Annals of the New York Academy of Sciences and The Journal of Infectious Diseases.

In The Last Decade

J Maral

28 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Maral France 10 133 105 101 71 61 29 344
Yushi Nakai Japan 10 68 0.5× 73 0.7× 166 1.6× 93 1.3× 171 2.8× 19 401
Linda A. Trimble United States 10 407 3.1× 205 2.0× 39 0.4× 50 0.7× 30 0.5× 17 575
Steven G. Roberts United States 9 85 0.6× 86 0.8× 51 0.5× 107 1.5× 345 5.7× 12 566
Klein Hg United States 8 56 0.4× 57 0.5× 73 0.7× 63 0.9× 20 0.3× 17 330
Johannes Mejer Denmark 10 59 0.4× 29 0.3× 179 1.8× 122 1.7× 50 0.8× 29 397
Juli Teague United States 6 139 1.0× 184 1.8× 100 1.0× 101 1.4× 44 0.7× 6 473
Francesca Romana Stefani Italy 10 69 0.5× 38 0.4× 66 0.7× 110 1.5× 47 0.8× 15 342
Patricia DeLora United States 8 45 0.3× 128 1.2× 59 0.6× 92 1.3× 12 0.2× 9 350
Leona Dold Germany 11 99 0.7× 37 0.4× 78 0.8× 89 1.3× 54 0.9× 35 513
Gudrun Ascherl Germany 7 63 0.5× 46 0.4× 314 3.1× 52 0.7× 22 0.4× 9 433

Countries citing papers authored by J Maral

Since Specialization
Citations

This map shows the geographic impact of J Maral's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Maral with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Maral more than expected).

Fields of papers citing papers by J Maral

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Maral. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Maral. The network helps show where J Maral may publish in the future.

Co-authorship network of co-authors of J Maral

This figure shows the co-authorship network connecting the top 25 collaborators of J Maral. A scholar is included among the top collaborators of J Maral based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Maral. J Maral is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Escuret, Vanessa, David Durantel, Romain Parent, et al.. (2006). Novel Alpha Interferon (IFN-α) Variant with Improved Inhibitory Activity against Hepatitis C Virus Genotype 1 Replication Compared to IFN-α2b Therapy in a Subgenomic Replicon System. Antimicrobial Agents and Chemotherapy. 50(12). 3984–3991. 6 indexed citations
2.
Lévy, Yves, Christine Durier, Roman Krzysiek, et al.. (2003). Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection. AIDS. 17(3). 343–351. 82 indexed citations
3.
4.
5.
Négrier, Sylvie, et al.. (2000). Long-term follow-up of patients with metastatic renal cell carcinoma treated with intravenous recombinant interleukin-2 in Europe.. PubMed. 6 Suppl 1. S93–8. 50 indexed citations
6.
Maral, J, et al.. (1996). PP-7-16 Cardioxane still induces effective cardioprotection in anthracycline pretreated breast cancer patients. European Journal of Cancer. 32. 48–48. 2 indexed citations
7.
Florentin, I., et al.. (1989). Modulation of immune responses in mice by oral administration of niflumic acid. International Journal of Immunopharmacology. 11(2). 173–183. 8 indexed citations
8.
Soubrane, Claude, C Jacobs, C Jacquillat, et al.. (1986). Laboratory Investigations / Influence of the Uremic State on the Development of Malignancy. American Journal of Nephrology. 6(5). 363–363. 4 indexed citations
9.
Florentin, I., Vincent Chung, J Maral, M. Bruley-Rosset, & G Mathé. (1985). Bacteria, bacterial fractions and products as immunomodulators I. International Journal of Immunopharmacology. 7(4). 611–611. 1 indexed citations
10.
Maral, J, et al.. (1985). Phase II evaluation of diaziquone (CI-904, AZQ) in the treatment of human malignant glioma. Journal of Neuro-Oncology. 3(3). 245–249. 15 indexed citations
11.
Jacquillat, C, D. Khayat, & J Maral. (1984). [Role of azlocillin in the treatment of immunocompromised patients. Results of the EORTC (European Organization for Research on the Treatment of Cancer) study)].. PubMed. 13(13). 838–40. 1 indexed citations
12.
Auclerc, Marie-Françoise, et al.. (1984). Prognostic value of lymphograms in chronic lymphatic leukemia. Cancer. 53(4). 888–895. 2 indexed citations
13.
Jacquillat, C, G Auclerc, F Baillet, et al.. (1984). [Primary chemotherapy in breast cancer. Preliminary results].. PubMed. 135(4). 291–5. 1 indexed citations
14.
Auclerc, G, et al.. (1983). [Acute leukemias and solid tumors in the course of Hodgkin disease].. PubMed. 70(1). 61–6. 3 indexed citations
15.
Maral, J, I. Florentin, C. Soubrane, & R Maral. (1983). [Cancer and immunosuppression : experimental aspects].. PubMed. 70(5). 351–71. 7 indexed citations
16.
Florentin, I., M. Hayat, N Kiger, et al.. (1983). Comparative analysis of the immunopharmacological properties of three new nitrosourea analogues: RPCNU, RFCNU and chlorozotocin. International Journal of Immunopharmacology. 5(3). 201–210. 7 indexed citations
17.
Jacquillat, C, Pierre Banzet, & J Maral. (1982). Clinical Trials of Chemotherapy and Chemoimmunotherapy in Primary Malignant Melanoma. Recent results in cancer research. 80. 254–258. 9 indexed citations
18.
Jacquillat, C, M Weil, J Maral, et al.. (1979). Clinical activity of detorubicin: a new anthracycline derivative.. PubMed. 63(5). 889–93. 6 indexed citations
19.
Jacquillat, C, Pierre Banzet, J Civatte, et al.. (1979). Adjuvant Chemotherapy or Chemoimmunotherapy in the Management of Primary Malignant Melanoma of Level III, IV, or V. Recent results in cancer research. 68. 346–358. 11 indexed citations
20.
Weil, M, Marie-Françoise Auclerc, J Maral, et al.. (1979). A survey of the anthracycline derivatives in hematology. Cancer Chemotherapy and Pharmacology. 2(1). 53–9. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yushi Nakai Breakdown of academic impact, for papers by Linda A. Trimble Breakdown of academic impact, for papers by Steven G. Roberts Breakdown of academic impact, for papers by Klein Hg Breakdown of academic impact, for papers by Johannes Mejer Breakdown of academic impact, for papers by Juli Teague Breakdown of academic impact, for papers by Francesca Romana Stefani Breakdown of academic impact, for papers by Patricia DeLora Breakdown of academic impact, for papers by Leona Dold Breakdown of academic impact, for papers by Gudrun Ascherl
Rankless by CCL
2026